Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a vaginal device ease endometriosis pain without hormones?

NCT ID NCT05643131

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 39 times

Summary

This study tests a new device called Hyivy that people with endometriosis can use at home. The device delivers gentle heat and stretches the vagina to help reduce chronic pelvic pain. Twenty adults with endometriosis and ongoing pelvic pain will use the device three times a week for 12 weeks. The goal is to see if their pain levels improve.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • McMaster University Medical Centre

    Hamilton, Ontario, L8N 3Z5, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hyivy Intravaginal Device (heat and dilation therapy)

What this could lead to

If it works, this could offer a non-hormonal, at-home option to help manage endometriosis-related pelvic pain.

What could go wrong

This is a very small, early pilot study with no control group, so results may not be conclusive. The device may not reduce pain for everyone.

Conditions

The condition(s) this trial relates to.

endometriosis Pelvic Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.